Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9390)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2018 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin EM, Gong J, Klempner SJ, Chao J. Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond. World J Gastroenterol 2018; 24(25): 2686-2697 [PMID: 29991874 DOI: 10.3748/wjg.v24.i25.2686] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i25/2686.htm |
| Number | Citing Articles |
| 1 |
Ran Duan, Xiaoqin Li, Dongqiang Zeng, Xiaofeng Chen, Bo Shen, Dongqin Zhu, Liuqing Zhu, Yangyang Yu, Deqiang Wang. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.609337
|
| 2 |
Yue Song, Zhaoming Li, Weili Xue, Mingzhi Zhang. Predictive Biomarkers for PD-1 and PD-L1 Immune Checkpoint Blockade Therapy. Immunotherapy 2019; 11(6): 515 doi: 10.2217/imt-2018-0173
|
| 3 |
Padmaraju Vasudevaraju, Malla Rama Rao. Immunotherapy for Gastrointestinal Malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 79 doi: 10.1007/978-981-15-6487-1_6
|
| 4 |
Koosha Paydary, Natalie Reizine, Daniel V. T. Catenacci. Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging Evidence. Cancers 2021; 13(23): 5929 doi: 10.3390/cancers13235929
|
| 5 |
Hans Juergen Grote, Zheng Feng, Michael Schlichting, Christoph Helwig, Mary Ruisi, Hulin Jin, Juergen Scheuenpflug, Claudia-Nanette Gann, Zhen Su, Martin Reck, Everett E. Vokes, Keith M. Kerr. Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay. Journal of Thoracic Oncology 2020; 15(8): 1306 doi: 10.1016/j.jtho.2020.04.013
|
| 6 |
Jianpeng Gao, Shiying Huo, Yu Zhang, Zhenxiong Zhao, Hongda Pan, Xiaowen Liu. Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patients. Cancer Medicine 2023; 12(1): 913 doi: 10.1002/cam4.4857
|
| 7 |
Gabriela Negrete-Tobar, Alejandro González-Motta, Oscar Alberto Messa-Botero, Juan Carlos Galvis, Isabella Garciandía Rozo, Juan Sebastián Álvarez Martínez, Juliana Pineda Ortega, Natalia Londoño de Vivero, Ricardo Bruges Maya. Inestabilidad microsatelital y cáncer gástrico. Revista Colombiana de Cirugía 2021; 36(1): 120 doi: 10.30944/20117582.658
|
| 8 |
Negar Khoshghamat, Niloufar Jafari, Mehrdad Moetamani-Ahmadi, Ghazaleh Khalili-Tanha, Mohammad-Hossein Khajavi rad, Saeed Sahebdel, Nima Khalili-Tanha, Saman Soleimanpour, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan. Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancers. Pathology - Research and Practice 2021; 220: 153390 doi: 10.1016/j.prp.2021.153390
|
| 9 |
Pierre Allemann, Pierre Fournier. Reflux Disease and Adenocarcinoma of the Esophagus and Cardia: Global Management and Surgical Treatment. Journal of Laparoendoscopic & Advanced Surgical Techniques 2020; 30(8): 869 doi: 10.1089/lap.2020.0079
|
| 10 |
Juliana Knief, Pamela Lazar-Karsten, Richard Hummel, Ulrich Wellner, Christoph Thorns. PD-L1 expression in carcinoma of the esophagogastric junction is positively correlated with T-cell infiltration and overall survival. Pathology - Research and Practice 2019; 215(6): 152402 doi: 10.1016/j.prp.2019.03.030
|
| 11 |
Jie Shi, Xu Yang, Xinmei Wang, Yufeng Luo, Weixun Zhou, Hanhuan Luo, Zhaxi Bianba, Zhuoma Nima, Qian Wang, Han Wang, Ruiqian Liao, Quzhen Ciren, Mei Li, Junyi Pang, Paulo Henrique Braz-Silva. Prevalence of Epstein–Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2684065
|
| 12 |
Yuting Pan, Yue Ma, Guanghai Dai. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy. Nutrients 2023; 15(19): 4290 doi: 10.3390/nu15194290
|
| 13 |
Adilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang, Ying Yuan. Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer. Critical Reviews in Oncology/Hematology 2022; 180: 103864 doi: 10.1016/j.critrevonc.2022.103864
|
| 14 |
Xiaoyang Duan, Huazhen Du, Ran Qi, Meng Yuan, Jian Shi. The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials. Experimental and Therapeutic Medicine 2023; 25(5) doi: 10.3892/etm.2023.11915
|
| 15 |
R. Sundar, K.K. Huang, A. Qamra, K.-M. Kim, S.T. Kim, W.K. Kang, A.L.K. Tan, J. Lee, P. Tan. Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer. Annals of Oncology 2019; 30(3): 424 doi: 10.1093/annonc/mdy550
|
| 16 |
Michele Ghidini, Angelica Petrillo, Andrea Botticelli, Dario Trapani, Alessandro Parisi, Anna La Salvia, Elham Sajjadi, Roberto Piciotti, Nicola Fusco, Shelize Khakoo. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. Journal of Clinical Medicine 2021; 10(7): 1412 doi: 10.3390/jcm10071412
|
| 17 |
Jia-Bin Wang, Ping Li, Xiao-Long Liu, Qiao-Ling Zheng, Yu-Bin Ma, Ya-Jun Zhao, Jian-Wei Xie, Jian-Xian Lin, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Li-Chao Liu, Ning-Zi Lian, Ying-Hong Yang, Chang-Ming Huang, Chao-Hui Zheng. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-20260-7
|
| 18 |
Gianluca Lopez, Konstantinos Venetis, Elham Sajjadi, Nicola Fusco. Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing. Gastrointestinal Disorders 2020; 2(4): 341 doi: 10.3390/gidisord2040031
|